Severity Of Illness Models For Respiratory Syncytial Virus–Associated Hospitalization
- 1 April 1999
- journal article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 159 (4) , 1234-1240
- https://doi.org/10.1164/ajrccm.159.4.9807075
Abstract
The objective of this investigation was to examine the feasibility of multivariate severity of illness models for pediatric patients hospitalized with respiratory syncytial virus (RSV) infection. From a pre- existing retrospective cohort study database, all infants and children 2 yr of age or younger with community-acquired RSV infection admitted to the University of Michigan's C. S. Mott Children's Hospital during nine epidemics were examined. The study group consisted of 802 hospitalized pa- tients younger than 2 yr of age with community-acquired RSV infection; 182 (23%) patients had pro- longed hospital length of stay defined as 7 d or greater. Multivariate logistic regression modeling of nine variables measurable during the first hospital day was strongly associated with prolonged hospi- talization (p , 0.0001). Receiver operator characteristic curve analysis resulted in an area under the curve of 0.894, indicating excellent model discrimination. Goodness-of-fit testing indicated excellent model calibration for observed versus predicted outcomes (p 5 0.216). We conclude that severity of illness models for RSV-associated hospitalization with excellent predictive properties in terms of clas- sification, discrimination, and calibration are possible. Further study is required to determine if such models are generalizable across multiple centers and epidemics. Moler FW, Ohmit SE. Severity of illness models for respiratory syncytial virus-associated hospitalization.Keywords
This publication has 26 references indexed in Scilit:
- Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk InfantsPediatrics, 1998
- Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failureThe Journal of Pediatrics, 1996
- Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infectionThe Journal of Pediatrics, 1995
- Does prematurity alter the course of respiratory syncytial virus infection?Critical Care Medicine, 1990
- Early ribavirin treatment of respiratory syncytial viral infection in high-risk childrenThe Journal of Pediatrics, 1990
- Aerosolized ribavirin in the treatment of patients with respiratory syncytial virus diseaseThe Pediatric Infectious Disease Journal, 1987
- Respiratory Syncytial Viral Infection in Children with Compromised Immune FunctionNew England Journal of Medicine, 1986
- Ribavirin aerosol for acute bronchiolitis.Archives of Disease in Childhood, 1986
- Aerosolized Ribavirin Treatment of Infants with Respiratory Syncytial Viral InfectionNew England Journal of Medicine, 1983
- Respiratory Syncytial Viral Infection in Infants with Congenital Heart DiseaseNew England Journal of Medicine, 1982